Virtus LifeSci Buy Hold or Sell Recommendation

BBC -- USA Etf  

USD 35.08  0.20  0.57%

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding Virtus LifeSci Biotech Clinical Trls ETF is 'Buy'. Macroaxis provides Virtus LifeSci buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BBC positions. The advice algorithm takes into account all of Virtus LifeSci Biotech available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from BBC buy-and-hold prospective. Check also Virtus LifeSci Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell Virtus LifeSciBuy Virtus LifeSci
Buy

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon Virtus LifeSci Biotech Clinical Trls ETF has a risk adjusted performance of 0.0673, jensen alpha of 0.1447, total risk alpha of 0.0062, sortino ratio of 0.1023 and treynor ratio of 0.1924
Virtus LifeSci Biotech recommendation module can be used to check and cross-verify current buy or sell recommendation provided by analysts inspecting the organization potential to grow using all of fundamental, technical, data market data available at the time. Please use Virtus LifeSci Biotech Total Asset, and the relationship between Price to Sales and Three Year Return to make buy, hold, or sell decision on Virtus LifeSci.

Virtus LifeSci Returns Distribution Density

Mean Return0.21Value At Risk2.53
Potential Upside2.84Standard Deviation1.58
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Niemann Capital Management IncFund Units507.2 K16.6 M

Virtus LifeSci Greeks

α
Alpha over DOW
=0.14
β
Beta against DOW=1.06
σ
Overall volatility
=1.55
Ir
Information ratio =0.09

Virtus LifeSci Volatility Alert

Virtus LifeSci Biotech Clinical Trls ETF has relatively low volatility with skewness of -0.09 and kurtosis of -0.37. However, we advise all investors to independently investigate Virtus LifeSci Biotech Clinical Trls ETF to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
    
 Better Than Average     
    
 Worse Than Average Compare Virtus LifeSci to competition

Virtus LifeSci Fundamental Vs Peers

FundamentalsVirtus LifeSciPeer Average
Price to Earning39.87 times8.24 times
Price to Book1.75 times0.97 times
Price to Sales1.99 times0.72 times
One Year Return30.82 % (1.25) %
Three Year Return5.26 % 2.26 %
Net Asset51.98 M888.73 M
Equity Positions Weight97.91 % 49.22 %

Virtus LifeSci Alerts

Trading Alerts and Improvement Suggestions

The fund holds 97.91% of its assets under management (AUM) in equities
Check also Virtus LifeSci Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Search macroaxis.com